CADI-R901

CADI-R901 is a therapeutic discovery program developed by Bio-Modeling Systems (BMSystems) using its proprietary Computer Assisted Deductive Integration (CADI™) platform. The program is focused on the mechanistic modeling of H-Ras-driven breast cancer to identify novel therapeutic targets and treatment strategies. BMSystems' CADI™ platform utilizes a non-mathematical, heuristic approach to integrate diverse biological data and describe the non-linear mechanisms of complex diseases. CADI-R901 is currently in the 'produced' stage, indicating that the biological model has been completed and validated in silico, and is available for further development or out-licensing. Although some pipeline summaries may associate the program with cardiovascular indications due to its placement in multi-domain lists, official company documentation identifies its primary focus as H-Ras-driven oncology.

Other names

CADI-R901-Bio-Modeling Systems-CardiovascularCADI-R-901-Bio-Modeling Systems-CardiovascularCADI-R 901-Bio-Modeling Systems-Cardiovascular